Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 394 Multiple Endocrine Neoplasia Type 1 156 Carcinoma, Neuroendocrine 123 Thyroid Cancer, Papillary 118 Pituitary Neoplasms 116 Thyroid Neoplasms 100 Pheochromocytoma 91 Neoplasms 79 Carcinoid Tumor 76 Thyroid Carcinoma, Anaplastic 73 Adrenocortical Carcinoma 73 Paraganglioma 65 Neoplasm Metastasis 56 Adenocarcinoma, Follicular 53 Carcinoma, Non-Small-Cell Lung 51 Carcinoma, Medullary 50 Insulinoma 49 Pancreatic Neoplasms 47 Adenoma, Islet Cell 47 Colorectal Neoplasms 44 Breast Neoplasms 44 Small Cell Lung Carcinoma 42 Sarcoma 42 Gastro-enteropancreatic neuroendocrine tumor 42 Carcinoma, Renal Cell 41 Somatostatinoma 38 Head and Neck Neoplasms 38 Melanoma 37 Lung Neoplasms 37 Adrenal Gland Neoplasms 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Digestive Neuroendocrine Tumors × Endocrine × Clear all

NCT02465112 2019-02-28

TERAVECT

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Terminated

Digestive Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡